Madison Avenue Partners, LP
NEW YORK, NY
$2.3bn in 25 US stocks at the end of 30 June 2026. The top 10 are 77.1% of the money. It changed about 31.1% of the portfolio this quarter.
Value
$2.3bn
Stocks
25
Top 10 share
77.1%
Turnover
31.1%
What changed this quarter
New
Bought for the first time this quarter.
- Invitation HomesINVH10.8% of the fund
- Octave IntelligenceOCTV3.0% of the fund
- SanminaSANM2.1% of the fund
- Primoris ServicesPRIM2.0% of the fund
- Array Digital InfrastructureAD1.7% of the fund
- Millrose PropertiesMRP0.4% of the fund
- MonroMNRO<0.1% of the fund
Added
Bought more of a stock they already held.
- Markel GroupMKL9.4% of the fund+28%
- CoupangCPNG9.3% of the fund+33%
- Staar SurgicalSTAA5.2% of the fund+71%
- Lakefront Biotherapeutics NVLKFT4.4% of the fund+40%
- Globus MedicalGMED3.2% of the fund+30%
Cut
Sold some of their stake.
- Magnum Ice CreamMICC8.2% of the fund-5%
- Theravance BiopharmaTBPH6.7% of the fund-3%
- SolventumSOLV5.8% of the fund-7%
- Indivior PharmaceuticalsINDV5.1% of the fund-33%
- British American Tobacco p.l.c.BTI2.8% of the fund-7%
- SandiskSNDK0.9% of the fund-98%
- SinclairSBGI0.8% of the fund-6%
- MagneraMAGN0.7% of the fund-18%
Sold out
Sold their entire stake.
- IconICLR-100%
- Molina HealthcareMOH-100%
- John Wiley & SonsWLY-100%
- Primo BrandsPRMB-100%
- DnowDNOW-100%
- Central BancompanyCBC-100%
- PAR TechnologyPAR-100%
- Franklin Street PropertiesFSP-100%
- SharkNinjaSN-100%
Holdings
- Theravance BiopharmaTBPH
- Share
- 6.7%
- Value
- $157m
- Shares
- 9,212,252
-3%
- Lakefront Biotherapeutics NVLKFT
- Share
- 4.4%
- Value
- $103m
- Shares
- 3,447,807
+40%
- Octave IntelligenceOCTV
- Share
- 3.0%
- Value
- $69m
- Shares
- 4,222,663
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Graham HoldingsGHC | 12.1% | $281m | 246,368 | Held |
| Invitation HomesINVH | 10.8% | $252m | 8,335,309 | New |
| Markel GroupMKL | 9.4% | $219m | 112,325 | +28% |
| CoupangCPNG | 9.3% | $216m | 12,457,195 | +33% |
| Magnum Ice CreamMICC | 8.2% | $190m | 10,892,592 | -5% |
| Theravance BiopharmaTBPH | 6.7% | $157m | 9,212,252 | -3% |
| SolventumSOLV | 5.8% | $134m | 1,741,221 | -7% |
| Staar SurgicalSTAA | 5.2% | $120m | 4,175,748 | +71% |
| Indivior PharmaceuticalsINDV | 5.1% | $118m | 2,874,368 | -33% |
| Lakefront Biotherapeutics NVLKFT | 4.4% | $103m | 3,447,807 | +40% |
| Globus MedicalGMED | 3.2% | $74m | 935,216 | +30% |
| Octave IntelligenceOCTV | 3.0% | $69m | 4,222,663 | New |
| British American Tobacco p.l.c.BTI | 2.8% | $64m | 1,043,302 | -7% |
| StagwellSTGW | 2.6% | $60m | 8,014,322 | Held |
| SanminaSANM | 2.1% | $48m | 188,322 | New |
| Primoris ServicesPRIM | 2.0% | $46m | 462,058 | New |
| Array Digital InfrastructureAD | 1.7% | $40m | 1,109,463 | New |
| Apartment Investment & ManagementAIV | 1.6% | $37m | 12,374,991 | Held |
| SandiskSNDK | 0.9% | $22m | 9,698 | -98% |
| Turning Point BrandsTPB | 0.9% | $21m | 247,823 | Held |
| SinclairSBGI | 0.8% | $20m | 1,383,470 | -6% |
| MagneraMAGN | 0.7% | $15m | 1,302,066 | -18% |
| Millrose PropertiesMRP | 0.4% | $9m | 298,461 | New |
| Keros TherapeuticsKROS | 0.3% | $7m | 626,583 | Held |
| MonroMNRO | <0.1% | $2m | 95,966 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 55.1% since 30 June 2025.
Where the money is
Health care26.2%
Retail & consumer21.5%
Real estate12.8%
Everyday goods11.8%
Financial services9.4%
Technology6.0%
Media & telecom5.1%
Industrials2.0%
Materials0.7%
Other4.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.